Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 49(7): 769-773, 2022 Jul.
Article in Japanese | MEDLINE | ID: mdl-35851348

ABSTRACT

Oxaliplatin is a platinum complex antineoplastic agent widely used for chemotherapy of colorectal cancer. However, one of its side effects is hypersensitivity reactions, the incidence of which increases with a cumulative dose, thereby posing a difficulty to continue oxaliplatin use. Our hospital changed the premedication of oxaliplatin in August 2009 and September 2012. We retrospectively investigated the usefulness of these premedication changes. The results showed no significant difference in the incidence of hypersensitivity between the control group(12.1%)and the group receiving H1 and H2-blockers (12.3%); however, the incidence of hypersensitivity was significantly reduced in the group receiving increased dexamethasone based on the number of courses(2.7%). Therefore, our regimen was found to be effective in preventing hypersensitivity reactions to oxaliplatin.


Subject(s)
Antineoplastic Agents , Drug Hypersensitivity , Antineoplastic Agents/adverse effects , Dexamethasone/therapeutic use , Drug Hypersensitivity/etiology , Drug Hypersensitivity/prevention & control , Humans , Oxaliplatin/adverse effects , Retrospective Studies
2.
J Membr Biol ; 251(1): 51-63, 2018 02.
Article in English | MEDLINE | ID: mdl-28993850

ABSTRACT

Vibrio alginolyticus is an opportunistic pathogen in both humans and marine animals. Collagenase encoded by colA is considered to be one of the virulence factors. Expression of colA is regulated by multiple environmental factors, e.g., temperature, growth phase, and substrate. To elucidate the mechanism of regulation of colA expression, transposon mutagenesis was performed. VarS, a sensor histidine kinase of the two-component regulatory system, was demonstrated to regulate the expression of colA. VarA, a cognate response regulator of VarS, was also identified and shown to be involved in the regulation of colA expression. In vitro phosphorylation assays showed that phosphorylated VarS acted as a phosphoryl group donor to VarA. A site-directed mutagenesis study showed that the His300, Asp718 and His874 residues in VarS were essential for the phosphorylation of VarS, and the Asp54 residue in VarA was likely to receive the phosphoryl group from VarS. The results demonstrate that the VarS/VarA two-component regulatory system regulates the expression of collagenase in V. alginolyticus.


Subject(s)
Bacterial Proteins/metabolism , Collagenases/metabolism , Vibrio alginolyticus/metabolism , Vibrio alginolyticus/pathogenicity , Virulence Factors/metabolism , Animals , Bacterial Proteins/genetics , Collagenases/genetics , Gene Expression Regulation, Bacterial , Humans , Mutagenesis, Site-Directed , Phosphorylation , Vibrio alginolyticus/genetics , Virulence Factors/genetics
4.
Biomicrofluidics ; 7(6): 64115, 2013.
Article in English | MEDLINE | ID: mdl-24396549

ABSTRACT

Understanding biomolecular gradients and their role in biological processes is essential for fully comprehending the underlying mechanisms of cells in living tissue. Conventional in vitro gradient-generating methods are unpredictable and difficult to characterize, owing to temporal and spatial fluctuations. The field of microfluidics enables complex user-defined gradients to be generated based on a detailed understanding of fluidic behavior at the µm-scale. By using microfluidic gradients created by flow, it is possible to develop rapid and dynamic stepwise concentration gradients. However, cells exposed to stepwise gradients can be perturbed by signals from neighboring cells exposed to another concentration. Hence, there is a need for a device that generates a stepwise gradient at discrete and isolated locations. Here, we present a microfluidic device for generating a stepwise concentration gradient, which utilizes a microwell slide's pre-defined compartmentalized structure to physically separate different reagent concentrations. The gradient was generated due to flow resistance in the microchannel configuration of the device, which was designed using hydraulic analogy and theoretically verified by computational fluidic dynamics simulations. The device had two reagent channels and two dilutant channels, leading to eight chambers, each containing 4 microwells. A dose-dependency assay was performed using bovine aortic endothelial cells treated with saponin. High reproducibility between experiments was confirmed by evaluating the number of living cells in a live-dead assay. Our device generates a fully mixed fluid profile using a simple microchannel configuration and could be used in various gradient studies, e.g., screening for cytostatics or antibiotics.

5.
Macromol Rapid Commun ; 33(10): 911-5, 2012 May 29.
Article in English | MEDLINE | ID: mdl-22389192

ABSTRACT

Square-millimeter-sized free-floating translucent films are formed in physiological buffer by multiway connections between biotinylated collagen-like triple-helical peptides and avidin. Although the compositions of the films are almost constant, regardless of the ratios of the components loaded, their thicknesses can be controlled by the concentrations of the components. The film surfaces can be further modified by taking advantage of exposed biotin (or avidin) functionalities. The self-assembled films could serve as novel materials in biomedical and biosensing applications.


Subject(s)
Collagen/chemistry , Peptides/chemistry , Amino Acid Sequence , Avidin/chemistry , Fluorescein/chemistry , Peptides/chemical synthesis , Protein Structure, Secondary , Rhodamines/chemistry , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL